In this article The U.S. will get less than half of Gilead Sciences Inc.’s worldwide donation of 1.5 million vials of its Covid-19 medicine over the next six weeks, which
Continue reading »Home »
Gilead CEO Says Over 50,000 Remdesivir Courses Ready to Ship
Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said there are more than 50,000 courses of the company’s experimental Covid-19 therapy, packed in vials and ready to ship as soon
Continue reading »